A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2009
10/08/2009	US20090253761 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
10/08/2009	US20090253732 Production Of Polyketides And Other Natural Products
10/08/2009	US20090253727 Nociceptin analogs
10/08/2009	US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use
10/08/2009	US20090253694 Fused hetrocyclic compounds
10/08/2009	US20090253686 Unsolvated benzodiazepine compositions and methods
10/08/2009	US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
10/08/2009	US20090253623 Gh secretagogues and uses thereof
10/08/2009	US20090253125 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
10/08/2009	US20090252763 Biological adjuvants
10/08/2009	US20090252762 novel proteosome-liposaccharide vaccine adjuvant
10/08/2009	US20090252760 Construction of Recombinant Adenovirus With Genes That Codify for SAG1, SAG2 and SAG3
10/08/2009	US20090252755 nucleic acid molecule comprising a hepatitis C virus (HCV) 5' untranslated region (UTR), produces a HCV that infects chimpanzees; for screening assays for the identification of antiviral agents for HCV
10/08/2009	US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009	US20090252741 Human monoclonal anti-ctla4 antibodies in cancer treatment
10/08/2009	US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof
10/08/2009	US20090252733 Generation and Profiling of Fully Human Gold-Derived Therapeutic Antibodies Specific for Human CD38
10/08/2009	US20090252705 IL-6/IL-6R Fusion Protein
10/08/2009	CA2720343A1 Heterocyclic derivative and use thereof
10/08/2009	CA2720277A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
10/08/2009	CA2719964A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof
10/08/2009	CA2718184A1 Agent for treating disease
10/07/2009	EP2107110A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
10/07/2009	EP2107070A1 Rheumatoid arthritis remedy containing IL-6 antagonist as active ingredient
10/07/2009	EP2107050A1 Lipoxin compounds
10/07/2009	EP2106801A1 IL-25 for use in the treatment of inflammatory diseases
10/07/2009	EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009	EP2106442A1 Cancerous disease modifying antibodies
10/07/2009	EP2106441A1 Cancerous disease modifying antibodies
10/07/2009	EP2106262A1 Novel prostate kallikrein allergen
10/07/2009	EP1617216B1 Novel method of screening
10/07/2009	EP1584627B1 Dimerized peptide
10/07/2009	EP1529038B1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
10/07/2009	EP1505075B1 Antibody to human insulin-like growth factor
10/07/2009	EP1392389B1 Microprojection array having a beneficial agent containing coating
10/07/2009	EP1385550B1 Therapeutic medicaments for inducing tolerance
10/07/2009	EP0907730B1 Haemopoietin receptor and genetic sequences encoding same
10/07/2009	CN101553228A Treatment of fibrosing disorders
10/07/2009	CN101553216A Treatment of inflammatory diseases
10/07/2009	CN101553214A Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
10/07/2009	CN101550193A Novel IZ-shGITRL fusion protein and preparation method and application thereof
10/07/2009	CN101550192A Monoclonal antibody K42-D2 of antihuman granzyme K and hybridoma cell line for excreting same
10/07/2009	CN101549146A Romurtide injection and preparation method thereof
10/07/2009	CN101549066A Prescription for treating allergy purpura and method for preparing same
10/07/2009	CN101549047A Five-element health-preserving capsule
10/07/2009	CN101549046A Health preserving product of north Chinese Caterpillar Fungus and glossy ganoderma
10/07/2009	CN101549043A Traditional Chinese medicine preparation and preparation method thereof
10/07/2009	CN101549042A Method for extracting amino acid from potatoes and application of extract thereof
10/07/2009	CN101549029A Compound Chinese herbal medicine immunopotentiator for fish
10/07/2009	CN101549010A A preparing method and application of malaytea scurfpea fruit total glycosides extract
10/07/2009	CN101548995A Application of Viscum album extract as NF-kB inhibitor
10/07/2009	CN101548989A Mactra veneriformis extract, preparation method and application thereof
10/07/2009	CN101548959A Coated tablet containing desloratadine and preparation method thereof
10/07/2009	CN100547003C Antibodies to human IL-1 beta
10/07/2009	CN100546977C New compounds for the inhibition of rotamases and use thereof
10/07/2009	CN100546586C Application of yew amylose in pharmacy
10/07/2009	CN100546580C Nicotin or isonicotin benzothiazole derivatives
10/06/2009	USRE40930 Porcine adenovirus type 3 genome
10/06/2009	US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/06/2009	US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
10/06/2009	US7598272 Kinase inhibitors
10/06/2009	US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
10/06/2009	US7598253 Reverse-turn mimetics and methods relating thereto
10/06/2009	US7598247 Immunomodulating heterocyclic compounds
10/06/2009	US7598244 (S)-1-(3-ethoxy-1-methylpropyl)-3-[7-(3,4-methylenedioxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea; preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease
10/06/2009	US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009	US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma
10/06/2009	CA2399971C Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
10/06/2009	CA2310888C Monoclonal human natural antibodies
10/01/2009	WO2009119874A1 Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity
10/01/2009	WO2009119858A1 Benzene compound, and use thereof for medical purposes
10/01/2009	WO2009119836A1 Composition for external application comprising transcription factor decoy as active ingredient
10/01/2009	WO2009119793A1 Method for production of transfected cell
10/01/2009	WO2009119785A1 Method for purifying ethynylthymidine compound
10/01/2009	WO2009119692A1 Novel glycolipid and use thereof
10/01/2009	WO2009119652A1 USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF α INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
10/01/2009	WO2009118243A1 Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
10/01/2009	WO2009117831A1 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
10/01/2009	WO2009117804A1 An anti-cancer cytotoxic monoclonal antibody
10/01/2009	WO2009080638A3 Sulfamides as zap-70 inhibitors
10/01/2009	WO2009033809A3 Use of a peptide as a therapeutic agent
10/01/2009	WO2009033730A3 Peptide gxgrgdspca as a therapeutic agent
10/01/2009	WO2009033666A3 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent
10/01/2009	US20090249519 Immunization of fish with plant-expressed recombinant proteins
10/01/2009	US20090247741 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/01/2009	US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009	US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
10/01/2009	US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
10/01/2009	US20090247589 Monocarboxylates for modifying macrophage function
10/01/2009	US20090247547 Hydroxamate-based inhibitors of deacetylases b
10/01/2009	US20090247508 Benzoimidazole Compounds
10/01/2009	US20090247507 Enzyme Inhibitors
10/01/2009	US20090247501 Protein kinase inhibitors
10/01/2009	US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
10/01/2009	US20090246855 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
10/01/2009	US20090246223 Inactivated Chimeric Vaccines and Related Methods of Use
10/01/2009	US20090246221 Immunomodulatory agents and methods of use
10/01/2009	US20090246215 Amyloid beta1-6 antigen arrays
10/01/2009	US20090246204 Use of a cd28 binding substance for making a pharmaceutical composition
10/01/2009	US20090246203 Method for immunoadsorption by means of autoanitgens

1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 1172